Currently, Medtronic is initiating many new product cycles, in markets like diabetes, pulse field ablation, TAVR, ...

The QPAN® Model, or QEEG-Guided Personalised AI-Based Neuromodulation and Rehabilitation, is an innovative therapeutic ...

Analyst reviews BrainsWay's rising share price and recent $20 million private placement, speculating on potential M&A plans ...

Approximately 10% to 20% of total knee arthroplasty (TKA) patients have persistent postoperative pain. Data from a new ...

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq:HSDT) has announced promising preliminary findings from its PoNSTEP study, which evaluates the impact of adherence to the Portable ...

Theranica, a prescribed neuromodulation therapeutics company, today announced Medicaid coverage for the Nerivio® REN wearable in four more states: Arizona, New Jersey, Ohio, and Virginia, extending ...

Remedee Labs, a startup based in Paris, France, has received a European approval for its device-based approach to treating ...

Hamad Medical Corporation (HMC) announcedthe launch of two innovative treatment options for patients with treatment resistant ...

RebrAIn, specialized in precise targeting solutions for DBS treatments and lesion techniques, completed the recruitment of ...

T. Rowe Price, a global investment management firm and leader in retirement, announced it is forming the T. Rowe Price ...

Hamad Medical Corporation (HMC) has launched two innovative options – Esketamine and Transcranial Magnetic Stimulation (TMS) ...

Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI scores from Phase ...